SCHEMBL11016342

SCHEMBL11016342

CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 7/20 0.72
NR3C1 P04150 6/20 0.72
PGR P06401 6/20 0.72
HIF1A Q16665 6/20 0.68
HSD17B10 Q99714 3/20 0.68
CYP3A4 P08684 3/20 0.68
ABCB11 O95342 3/20 0.68
AR P10275 2/20 0.68
TNF P01375 1/20 0.68
IL6 P05231 1/20 0.68
SERPINA6 P08185 1/20 0.68
GLUL P15104 1/20 0.68
ADAM17 P78536 1/20 0.68
GPBAR1 Q8TDU6 1/20 0.68
CYP2C19 P33261 1/20 0.68
LMNA P02545 3/20 0.68
CYP2C9 P11712 2/20 0.68
USP2 O75604 1/20 0.68
CYP2D6 P10635 1/20 0.68
KMT2A Q03164 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6857090 1.00 NR3C2 (0.72) NR3C2NR3C1PGRHIF1AHSD17B10
SCHEMBL6857093 1.00 NR3C2 (0.72) NR3C2NR3C1PGRHIF1AHSD17B10
Prednival SCHEMBL11585728 0.96 HIF1A (0.73) NR3C2NR3C1PGRHIF1AHSD17B10
Prednival SCHEMBL25387 0.96 HIF1A (0.73) NR3C2NR3C1PGRHIF1AHSD17B10
Prednival SCHEMBL25388 0.96 HIF1A (0.73) NR3C2NR3C1PGRHIF1AHSD17B10
Prednival SCHEMBL2966212 0.96 HIF1A (0.73) NR3C2NR3C1PGRHIF1AHSD17B10
Prednival SCHEMBL2966209 0.96 HIF1A (0.73) NR3C2NR3C1PGRHIF1AHSD17B10
SCHEMBL7984 0.94 NR3C2 (0.74) NR3C2NR3C1PGRHIF1AHSD17B10
SCHEMBL7142733 0.94 NR3C2 (0.74) NR3C2NR3C1PGRHIF1AHSD17B10
SCHEMBL7613014 0.94 NR3C2 (0.74) NR3C2NR3C1PGRHIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116348093-A Pharmaceutical composition of intra-articular corticosteroid for pain control TLC生物医药公司 2023-06-27 CN claimed
CN-112702993-A Pharmaceutical compositions suitable for joint delivery and their use in the treatment of joint pain TLC生物医药公司 2021-04-23 CN claimed
CN-112469420-A Method for reducing complications of steroids in joints 台湾微脂体股份有限公司 2021-03-09 CN claimed
US-4478818-A Ocular preparation housing steroid in two different therapeutic forms ALZA CORPORATION (US) 1984-10-23 US claimed
CN-119490468-A Solid forms of acanthogenesis promoting agent 斯皮诺吉尼克斯公司 2025-02-21 CN disclosed
CN-119235874-A Combination therapy for prostate cancer 詹森药业有限公司 2025-01-03 CN disclosed
CN-116024266-A Compositions and methods for treating leber's hereditary optic neuropathy due to ND4 mutations 武汉纽福斯生物科技有限公司 2023-04-28 CN disclosed
CN-217612538-U Brachytherapy applicator device 萨鲁塔利斯医疗设备有限公司 2022-10-21 CN disclosed
CN-114901295-A Chimeric antigen receptor T cell therapy 凯德药业股份有限公司 2022-08-12 CN disclosed
CN-114698370-A Compounds and methods for treating cytokine release syndrome 里格尔药品股份有限公司 2022-07-01 CN disclosed
CN-114466658-A Orally delivered therapeutic compositions and uses thereof 沈海发 2022-05-10 CN disclosed
CN-114286679-A Methods of blocking or ameliorating cytokine release syndrome 里格尔药品股份有限公司 2022-04-05 CN disclosed
CN-108697713-B Methods for making tricyclic PI3K inhibitor compounds and methods of treating cancer therewith 基因泰克公司 2021-10-26 CN disclosed
CN-112584874-A Compositions and methods for treating leber's hereditary optic neuropathy 武汉纽福斯生物科技有限公司 2021-03-30 CN disclosed
CN-107530339-B Glucocorticoid receptor antagonists in combination with glucocorticoids for the treatment of adrenal insufficiency 科赛普特治疗学股份有限公司 2021-03-16 CN disclosed
CN-110753545-A Combination therapy for prostate cancer 詹森药业有限公司 2020-02-04 CN disclosed
EP-0144086-A2 Hydrocortisone and prednisolone derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1985-06-12 EP disclosed
US-4478818-A Ocular preparation housing steroid in two different therapeutic forms ALZA CORPORATION (US) 1984-10-23 US disclosed
US-4432964-A Topical composition containing steroid in two forms released independently from polymeric carrier ALZA CORPORATION (US) 1984-02-21 US disclosed
US-4304765-A Ocular insert housing steroid in two different therapeutic forms ALZA CORPORATION (US) 1981-12-08 US disclosed